5 unknown. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Unknown 5 |
Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise N-acetyl cystein, Placebo - G6PD Deficiency | Early Phase 1 | Unknown | University of Thessaly | 12 | 2023-02-01 | 2022-01-05 |
| A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis CD19/BCMA CAR T-cells - POEMS Syndrome, Amyloidosis | Early Phase 1 | Unknown | Zhejiang University | 75 | 2021-10-08 | 2022-03-03 |
| iHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations iHSCs treatment group - Thalassemia | Early Phase 1 | Unknown | Allife Medical Science and Technology Co., Ltd. | 12 | 2019-01-01 | 2018-11-05 |
| Therapeutic Effect of Colla Corii Asini on Improving Anemia and Hemoglobin Composition in Pregnant Women With Thalassemia Colla corii asini - Thalassemia | Early Phase 1 | Unknown | Yanfang Li | 90 | 2015-03-01 | 2016-05-13 |
| Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia Lenalidomide + Ancestim - Myelodysplasia | Early Phase 1 | Unknown | Peter MacCallum Cancer Centre, Australia | 25 | 2007-02-01 | 2013-01-10 |
Thalassemia (2) · Amyloidosis (1) · Anemia, Hemolytic, Autoimmune (1) · Anemia, Refractory, with Excess of Blasts (1) · Glucosephosphate Dehydrogenase Deficiency (1) · POEMS Syndrome (1) · Vasculitis (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Anemia, Hemolytic (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Anemia, Hemolytic, Congenital (3) · Genetic Diseases, Inborn (3) · Hemoglobinopathies (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Abnormalities, Multiple (1) · Anemia, Refractory (1) · Autoimmune Diseases (1) · Blood Protein Disorders (1) · Bone Marrow Diseases (1)
Lenalidomide (1) · ancestim (1) · colla corii asini (1) · ethofenprox (1)
Allife Medical Science and Technology Co., Ltd. (1) · Peter MacCallum Cancer Centre, Australia (1) · University of Thessaly (1) · Yanfang Li (1) · Zhejiang University (1)
China (2) · Australia (1) · Greece (1)
Athanasios Z Jamurtas, PhD (1) · He Huang, PhD (1) · Miles Prince, Prof. (1)